Fibrinogen and altered hemostasis in Alzheimer's disease - Wikidata - awgldk - TriplyDB

Fibrinogen and altered hemostasis in Alzheimer's disease

Fibrinogen and altered hemostasis in Alzheimer's disease

http://www.wikidata.org/entity/Q38032520

about

The pericyte: a forgotten cell type with important implications for Alzheimer's disease?Contribution of blood platelets to vascular pathology in Alzheimer's disease Dynamic self-guiding analysis of Alzheimer's disease.Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'.A regenerative label-free fiber optic sensor using surface plasmon resonance for clinical diagnosis of fibrinogen Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease.The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.Repeated systemic inflammation was associated with cognitive deficits in older Britons The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients.Migration of blood cells to β-amyloid plaques in Alzheimer's disease.Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis.Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes.A derangement of the brain wound healing process may cause some cases of Alzheimer's disease.Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice.Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia

P2860

Q26852369-195ECCE5-532A-45D3-934C-464BC7C2DD95 Q26861509-B4674154-AD61-4EA2-88C0-3DB641EBF63E Q28080897-D8352ED5-F3D5-4BFF-B03F-10AEEB5F46E0 Q33717021-CF474256-BAF6-466E-A20E-47E0980573FB Q35581060-C6F05E2F-EFCC-4EE8-AB77-FE8DFF1A69A4 Q36015965-EEBC4238-380C-4824-825A-C32E4C7F599F Q36773984-F3223E9C-D275-48D9-8ACC-C96116A1098F Q36909451-EA0CEE22-8562-4491-9402-18EC2A6FF8C2 Q36934141-2EDFC023-D2F0-4613-B8AD-A6F325379C97 Q37073413-319D7595-AB0A-4D3A-B0EC-18EEC1ED1391 Q37346081-EE10112E-8909-41B3-AE3D-51C03AB91380 Q38370756-D52DB19F-7DA6-46EA-8FC5-CCCF61E93581 Q38871578-D9D95C51-9A4F-4304-A9B8-1FCBD5EC526C Q41916686-A2132C50-979C-472E-8C87-75419B91D815 Q42281478-4B7BD37F-F1A2-4B82-BEFA-B17CB821225E Q42352233-AD5BF548-864F-4FE9-BA8B-D7C13F0D6EE2 Q42365639-95646642-B254-4092-AFD6-29A097D29A4B Q48289507-A9D8EF92-8A20-4660-A4D6-1C85B0705442 Q49374917-584F5686-DCCA-4476-8B17-CE1851F8C857 Q50221800-72E4039E-EEE3-4288-8F0A-8ABD1B59E3EF Q50288922-98C1B3F9-4020-47FE-AAC8-A9154D288859 Q53698735-07B12548-3756-4658-8021-C3F189100ECB Q54229364-751E239B-F93D-4319-A2FD-18AA6CC1364A Q55379242-604D7604-8FCF-452A-886D-163E2BC5C3F6 Q58719165-DB364A25-DDB5-4625-801C-6F5911283740

P2860

Fibrinogen and altered hemostasis in Alzheimer's disease

http://www.wikidata.org/entity/Q38032520

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Fibrinogen and altered hemostasis in Alzheimer's disease

@en

type

label

Fibrinogen and altered hemostasis in Alzheimer's disease

@en

prefLabel

Fibrinogen and altered hemostasis in Alzheimer's disease

@en

P1433

Q38032520-69635ED6-E1D3-492A-8177-A400C17BE3D1

P1476

Q38032520-CEE98FAB-4254-4706-856C-C9D98DA9EF68

P2093

Q38032520-24DB9778-6DF0-462F-A03C-153BE331598D

Q38032520-266F53F8-93A0-4F20-AF65-5D2483C6AA81

Q38032520-42E7F501-68D4-4FA5-95C2-A293D67BCE6F

Q38032520-615CAFD3-5716-42AB-8D1F-0DAA94FAD683

Q38032520-C1A0044D-C8C0-491B-A01F-822D3DC3549E

P2860

Q38032520-029D06F5-3736-4779-9BE1-E4F68EC56727

Q38032520-04A9CDB8-D4EF-4FD4-92EA-B19F3DC40502

Q38032520-08B6AC78-5CF2-4345-A139-6EAD1108E380

Q38032520-09E9F309-4E21-4D71-BA21-71790D0F75ED

Q38032520-0B05CDB2-07A2-4C00-9C45-D24BD658FF11

Q38032520-0CB0F2AF-195B-414E-BE66-8875A563E1FB

Q38032520-105F7ADB-93CE-4F3F-B301-C262D9915A13

Q38032520-117E0B66-2419-491E-80AA-003B2E362B86

Q38032520-168FA3E5-E583-4D0C-81D5-258BF998145B

Q38032520-28825B5B-AA54-4EF9-9747-FF244AFEDE72

P304

Q38032520-1E7E561E-965D-46BA-9D2A-B1EBA415482B

P31

Q38032520-3127673A-9ACA-428D-B5CA-FA2D6D7FBC88

P356

Q38032520-0825567F-15B2-413B-89B2-F0ED39C07CC6

P433

Q38032520-CE68399D-8A61-4F0D-943A-94D674AB3218

P478

Q38032520-1B67066B-6C14-4EBB-8FAA-E94193E0BD48

P577

Q38032520-46BDAD7C-59CC-47F5-ABA3-3A247C86AC0C

P5875

Q38032520-FE0868A1-BF78-435C-BA91-723F970B2DEC

P698

Q38032520-D0DFBC65-39D7-42DF-BE01-405018D2BB5C

P921

Q38032520-27919CB0-B27E-4E38-924C-36B8C3A855E4

P932

Q38032520-3A2E85D3-70D9-4BEB-9969-0A2958EC2000

P356

JAD-2012-120820

P1433

Journal of Alzheimer's Disease

P1476

Fibrinogen and altered hemostasis in Alzheimer's disease

@en

P2093

Daria Zamolodchikov

http://www.w3.org/2001/XMLSchema#string

Erin H Norris

http://www.w3.org/2001/XMLSchema#string

Hyung Jin Ahn

http://www.w3.org/2001/XMLSchema#string

Marta Cortes-Canteli

http://www.w3.org/2001/XMLSchema#string

Sidney Strickland

http://www.w3.org/2001/XMLSchema#string

P2860

Clearance of amyloid-beta by circulating lipoprotein receptors

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Determinants of platelet activation in Alzheimer's disease

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

Plasma biomarkers of brain atrophy in Alzheimer's disease

Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease

Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo

Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics.

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

P304

599-608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2012-120820

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230623761

http://www.w3.org/2001/XMLSchema#string

P698

22869464

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3683985

http://www.w3.org/2001/XMLSchema#string